Correction: Revised free light chain reference intervals enhance risk stratification in monoclonal gammopathy of undetermined significance and reduce overdiagnosis

Correction: Revised free light chain reference intervals enhance risk stratification in monoclonal gammopathy of undetermined significance and reduce overdiagnosis

Saved in:

Bibliographic Details
Main Authors:	Cecilie Velsoe Maeng, Sæmundur Rögnvaldsson, Thórir Einarsson Long, Christian Brieghel, Emil Hermansen, Carsten Utoft Niemann, Kirsten Grønbæk, Sigurður Yngvi Kristinsson, Sigrún Thorsteinsdóttir
Format:	Article
Language:	English
Published:	Nature Publishing Group 2025-05-01
Series:	Blood Cancer Journal
Online Access:	https://doi.org/10.1038/s41408-025-01307-8
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Revised free light chain reference intervals enhance risk stratification in monoclonal gammopathy of undetermined significance and reduce overdiagnosis
by: Cecilie Velsoe Maeng, et al.
Published: (2025-04-01)

Monoclonal gammopathy of undetermined significance with multiple paraproteins: A population‐based screening study
by: Sæmundur Rögnvaldsson, et al.
Published: (2024-11-01)

Deep immune cell profiling in blood and bone marrow of early stage monoclonal gammopathy: an iStopMM and ECRIN-M3 collaborative study
by: Oihane Pérez-Escurza, et al.
Published: (2025-03-01)

Association of Pulmonary Hypertension and Monoclonal Gammopathy of Undetermined Significance
by: Melissa A. Lyle, et al.
Published: (2022-01-01)

Prevalence of monoclonal gammopathy of undetermined significance in Shenzhen, China
by: Anping Xu, et al.
Published: (2024-12-01)

Screening for monoclonal gammopathies of undetermined significance: A prospective study
by: Aissam El Maataoui, et al.
Published: (2025-03-01)

Monoclonal Gammopathy of Undetermined Significance Disguised as Chronic Neutrophilic Leukemia
by: Monique A Hartley-Brown, et al.
Published: (2010-02-01)

A Real-World International Staging System (RW-ISS) for patients with newly diagnosed multiple myeloma
by: Christian Brieghel, et al.
Published: (2025-04-01)

Distress and symptom burden in patients with monoclonal gammopathy of undetermined significance and smoldering myeloma
by: Elizabeth K. O’Donnell, et al.
Published: (2025-04-01)

The role of bone marrow microenvironment in the progression of multiple myeloma from monoclonal gammopathy of undetermined significance
by: A. S. Khudovekova, et al.
Published: (2021-09-01)

Monoclonal gammopathy of undetermined significance with associated necrotizing myopathy: a case report and review of the literature
by: Anna Bode, et al.
Published: (2025-04-01)

Sarcoidosis and Monoclonal Gammopathy of Undetermined Significance (MGUS): A True Association or Just a Coincidence?
by: Mohamed Hassanein, et al.
Published: (2018-01-01)

PARAPROTEINEMIC POLYNEUROPATHY ASSOCIATED WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE: СLINICAL CASE DESCRIPTION AND LITERATURE REVIEW
by: A. A. Yakovlev, et al.
Published: (2017-09-01)

Case Report: IgG4-RD-related ophthalmopathy combined with monoclonal gammopathy of undetermined significance
by: Shanshan Liang, et al.
Published: (2025-05-01)

Successful Daratumumab, Lenalidomide, and Dexamethasone Treatment of Refractory Type I Cryoglobulinemia From Monoclonal Gammopathy of Undetermined Significance
by: Karen J. Shou, et al.
Published: (2024-11-01)

Prognostic Value of Hepatocyte Growth Factor, Syndecan-1, and Osteopontin in Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance
by: Jiri Minarik, et al.
Published: (2012-01-01)

Synovitis, acne, pustular lesions, hyperostosis, and osteitis syndrome associated with monoclonal gammopathy of undetermined significance: a case report
by: Cheng Xu, et al.
Published: (2025-07-01)

Successful Treatment of Concomitant Pleural Mucosa-Associated Lymphoid Tissue Lymphoma and Monoclonal Gammopathy of Undetermined Significance with Lenalidomide, Rituximab, and Dexamethasone
by: Yoshiki Uemura, et al.
Published: (2022-01-01)

The specific transcriptional profile and clonal selection of monoclonal gammopathy of undetermined significance-like behavior predict an exceptionally favorable prognosis in multiple myeloma
by: Wenqiang Yan, et al.
Published: (2025-04-01)

Multiparameter flow cytometric and transcriptional analyis of CD20 positive T-cells in bone marrow in patients of multiple myeloma and monoclonal gammopathy of undetermined significance
by: Barbara Forró, et al.
Published: (2025-02-01)

Mutational Landscape of Bone Marrow CD19 and CD138 Cells in Waldenström Macroglobulinemia (WM) and IgM Monoclonal Gammopathy of Undetermined Significance (IgM MGUS)
by: Alessandra Trojani, et al.
Published: (2024-12-01)

Successful Management of Acquired von Willebrand Syndrome Associated with Monoclonal Gammopathy of Undetermined Significance After Sotorasib Treatment in a Patient with Non-Small-Cell Lung Carcinoma
by: Mélissa Julien, et al.
Published: (2025-04-01)

Overdiagnosis of pneumonia in children
by: D Anadol, et al.
Published: (2001-07-01)

Assessing the performance of the Iceland screens, treats, or prevents multiple myeloma (iStopMM) model in a multicultural Bronx cohort: implications for monoclonal gammopathy of undetermined significance risk stratification
by: Rajvi Gor, et al.
Published: (2025-08-01)

Overdiagnosis and Overtreatment in Prostate Cancer
by: Zaure Dushimova, et al.
Published: (2025-05-01)

Overdiagnosis of epithelial abnormalities in atrophic cervical pap smears unmasking overdiagnosis in atrophic pap smears
by: Fasahath Jahan Uzma, et al.
Published: (2024-11-01)

Unusual Cases of Monoclonal Gammopathy of Renal Significance
by: Anjellica Chen, et al.
Published: (2024-01-01)

WCN25-4500 INCIDENCE AND RISK FACTORS FOR MONOCLONAL GAMMOPATHY OF RENAL SIGNIFICANCE (MGRS) IN PATIENTS WITH MONOCLONAL GAMMOPATHY AND RENAL DISEASE
by: Henrique Borges, et al.
Published: (2025-02-01)

Monoclonal gammopathy of renal significance: From bench to bedside
by: Megha Saigal, et al.
Published: (2025-01-01)

Monoclonal gammopathy in WHIM syndrome can mask hypogammaglobulinemia
by: Julia Lew, MD, et al.
Published: (2025-08-01)

Bortezomib maintenance for the treatment of Monoclonal Gammopathy of Renal Significance
by: Holly Lee, et al.
Published: (2019-01-01)

Clinical diagnosis of TB: lessons on misdiagnosis and overdiagnosis
by: D.S. Singini, et al.
Published: (2025-06-01)

The problem of overdiagnosis of vertebral artery compression syndrome
by: A. N. Shvedov, et al.
Published: (2021-07-01)

Mast cell activation syndrome: The overdiagnosis problems
by: N. V. Mikryukova, et al.
Published: (2025-06-01)

CLINICAL OVERDIAGNOSIS OF DESTRUCTIVE FORMS OF PULMONARY TUBERCULOSIS
by: Yu. R. Zyuzya, et al.
Published: (2019-07-01)

Kidney involvement in monoclonal gammopathies: multidisciplinary approach in oncohematology and nephrology
by: A. V. Smirnov, et al.
Published: (2020-07-01)

Transient Monoclonal Gammopathy Induced by Disseminated Staphylococcus aureus Infection
by: Dimitrios Stoimenis, et al.
Published: (2012-01-01)

Overdiagnosis of Bipolar Disorder: A Critical Analysis of the Literature
by: Amna A. Ghouse, et al.
Published: (2013-01-01)

HIGH PREVALENCE OF REACTIVE ARTHRITIS IN RUSSIA: OVERDIAGNOSIS OR REALITY?
by: R. M. Balabanova, et al.
Published: (2016-02-01)

Difficult diagnosis. Clinical analysis of pneumonia overdiagnosis case
by: Pertseva T.A., et al.
Published: (2013-10-01)